Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
AONC
American Oncology Network Inc.
American Oncology Network Inc. (AONC) is rated C (2.3/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (B-); its weakest is Profitability (D+).
Quantitative Factor Evaluation • Updated
Overall Rating
2.3
/ 5.0
C
Value
C
Factor Score
2.4
/ 5.0
Growth
B-
Factor Score
3.0
/ 5.0
Profitability
D+
Factor Score
1.7
/ 5.0
Momentum
C
Factor Score
2.4
/ 5.0
Revisions
C-
Factor Score
1.9
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
0.0
EV / EBITDA
238.1
Rev Growth YoY
51.4%
Gross Margin
6.8%
Price Return 3M
11.1%
Price Return 12M
N/A
Catalyst Signal
0.00
Market Cap
N/A
TTM Revenue
N/A
Price / Sales
0.2
ROE
-30.2%
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-08-05 | C (2.4) | B- (3.0) | D+ (1.7) | C (2.4) | C- (1.9) | C (2.3) |
| 2026-08-04 | C (2.5) | B- (3.0) | D+ (1.7) | C (2.4) | C- (1.9) | C (2.3) |
| 2026-08-03 | C (2.4) | C+ (2.6) | C (2.2) | C (2.4) | C- (2.0) | C (2.3) |
| 2026-08-02 | C (2.5) | C+ (2.6) | C- (2.1) | C (2.4) | C- (1.9) | C (2.3) |